Drug intelligence / Profile preview

Baoshen Fang

Development stage: Preclinical
Lead developer: Second Hospital of Lanzhou University
Administration: Oral

Overview

Baoshen Fang (宝肾方) is a Traditional Chinese Medicine (TCM) prescription or formula currently undergoing integrated development of its active components for the treatment of chronic kidney disease. Rooted in traditional Chinese medical theory, its therapeutic action is generally understood to involve harmonizing yin and yang, warming and tonifying kidney yang, and strengthening the body's fundamental resistance. It is typically administered orally.

Other names: 宝肾方

Beyond the preview

Go deeper on Baoshen Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baoshen Fang.

Explore the full profile